Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis
- 8 September 2010
- journal article
- Published by Royal Society of Chemistry (RSC) in Molecular BioSystems
- Vol. 6 (11), 2316-2324
- https://doi.org/10.1039/c0mb00104j
Abstract
There is an urgent need for new drugs against tuberculosis which annually claims 1.7–1.8 million lives. One approach to identify potential leads is to screen in vitro small molecules against Mycobacterium tuberculosis (Mtb). Until recently there was no central repository to collect information on compounds screened. Consequently, it has been difficult to analyze molecular properties of compounds that inhibit the growth of Mtb in vitro. We have collected data from publically available sources on over 300000 small molecules deposited in the Collaborative Drug Discovery TB Database. A cheminformatics analysis on these compounds indicates that inhibitors of the growth of Mtb have statistically higher mean logP, rule of 5 alerts, while also having lower HBD count, atom count and lower PSA (ChemAxon descriptors), compared to compounds that are classed as inactive. Additionally, Bayesian models for selecting Mtb active compounds were evaluated with over 100000 compounds and, they demonstrated 10 fold enrichment over random for the top ranked 600 compounds. This represents a promising approach for finding compounds active against Mtb in whole cells screened under the same in vitro conditions. Various sets of Mtb hit molecules were also examined by various filtering rules used widely in the pharmaceutical industry to identify compounds with potentially reactive moieties. We found differences between the number of compounds flagged by these rules in Mtb datasets, malaria hits, FDA approved drugs and antibiotics. Combining these approaches may enable selection of compounds with increased probability of inhibition of whole cell Mtb activity.Keywords
This publication has 37 references indexed in Scilit:
- Virtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthaseBioorganic & Medicinal Chemistry, 2010
- A collaborative database and computational models for tuberculosis drug discoveryMolecular BioSystems, 2010
- Antituberculosis activity of the molecular libraries screening center network libraryTuberculosis, 2009
- High-throughput screening for inhibitors of Mycobacterium tuberculosis H37RvTuberculosis, 2009
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan SynthesisScience, 2009
- Structure−Activity Relationships of Antitubercular Nitroimidazoles. 2. Determinants of Aerobic Activity and Quantitative Structure−Activity RelationshipsJournal of Medicinal Chemistry, 2009
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO ReleaseScience, 2008
- Global Bayesian Models for the Prioritization of Antitubercular AgentsJournal of Chemical Information and Modeling, 2008
- Inhibition of Siderophore Biosynthesis by 2-Triazole Substituted Analogues of 5′-O-[N-(Salicyl)sulfamoyl]adenosine: Antibacterial Nucleosides Effective against Mycobacterium tuberculosisJournal of Medicinal Chemistry, 2008
- Discovery of Novel Nitrobenzothiazole Inhibitors for Mycobacterium tuberculosis ATP Phosphoribosyl Transferase (HisG) through Virtual ScreeningJournal of Medicinal Chemistry, 2008